SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is trending following the announcement of a private debt exchange that will reduce long-term obligations by converting notes into equity, a move that has sparked intense debate among retail investors regarding potential dilution versus long-term balance sheet strengthening. The community remains deeply divided, with some users speculating the move is a strategic precursor to a major acquisition, while others express frustration over management's capital allocation and the impact on share value.

RUM Group, Inc. engages in operating an online neutral video platform. It operates through the following geographical segments: United States, Canada, and Other. The company was founded in October 2013 by Chris Pavlovski and is headquartered in Longboat Key, FL.

RUM Group Inc. - Ordinary Shares - Class A

RUM Group Inc.

Rumble is trending as retail investors rally around a potential short squeeze, fueled by high short interest and anticipation surrounding the company's Q2 earnings and first-ever formal financial guidance. The community remains heavily focused on the company's shift toward AI infrastructure through the Northern Data acquisition and its strategic cloud partnerships, which bulls believe will fundamentally reprice the stock once institutional investors take note.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics is attracting significant attention as investors react to a combination of strong commercial momentum for its MS franchise and persistent short interest, fueling active community debate regarding a potential buyout or long-term valuation expansion. Despite volatility, proponents remain focused on the companys upcoming subcutaneous program and potential label expansions in secondary indications as key catalysts for future growth.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

The S&P 500 is surging toward all-time highs as a massive short squeeze unfolds, fueled by market optimism surrounding potential diplomatic talks with Iran and coordinated currency interventions. Community members are actively debating the sustainability of this aggressive melt-up, with many traders questioning the validity of the underlying news catalysts while bulls remain focused on the strength of recent momentum.

Celsius Holdings, Inc. engages in the development, marketing, sale, and distribution of functional drinks and liquid supplements. It also offers post-workout functional energy drinks and protein bars. The company was founded in April 2004 and is headquartered in Boca Raton, FL.

Celsius Holdings Inc

Celsius is facing significant downward pressure and setting new lows as the market rotates out of high-growth names, leading the community to debate whether current prices represent a generational buying opportunity or a deeper fundamental decline. Investors remain sharply divided, with bulls pointing to historical buyback potential and strong brand momentum while bears cite increasing competitive headwinds and margin pressures ahead of the upcoming earnings release.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is facing intense investor speculation as the community eagerly anticipates Phase 3 IZAR-1 trial results, with sentiment split between confidence in 'best-in-class' outcomes and frustration over the delayed timeline. Active discussions focus on interpreting management's 'about a month' guidance, the potential for a transformative partnership or buyout, and the impact of heavy institutional ownership on current price volatility.

The Boeing Co. is an aerospace company, which engages in the manufacture of commercial jetliners and defense, space, and security systems. It operates through the following segments: Commercial Airplanes (BCA), Defense, Space and Security (BDS), and Global Services (BGS). The Commercial Airplanes segment includes the development, production, and market of commercial jet aircraft and provides fleet support services, principally to the commercial airline industry worldwide. The Defense, Space and Security segment refers to the research, development, production and modification of manned and unmanned military aircraft and weapons systems for global strike, including fighter and combat rotorcraft aircraft and missile systems, global mobility, including tanker, rotorcraft and tilt-rotor aircraft, and airborne surveillance and reconnaissance, including command and control, battle management and airborne anti-submarine aircraft. The Global Services segment provides services to commercial and defense customers. The company was founded by William Edward Boeing on July 15, 1916, and is headquartered in Arlington, VA.

Boeing Co.

Boeing Co

Boeing is trending as investors react to the FAA's certification of the 737 MAX-7, a long-awaited milestone that serves as a key catalyst for potential delivery momentum and cash flow recovery. The community is actively debating whether this certification signals a sustained turnaround for the companys broader aircraft backlog or if the stock will continue to face volatility from ongoing execution challenges and defense-related cost pressures.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavax is currently trending as investors brace for the upcoming earnings call, with community sentiment deeply polarized between frustration over stagnant share price performance and optimism surrounding the potential for proprietary Matrix-M licensing deals. The discussion is heavily focused on the company's strategic pivot toward a leaner licensing model, with many participants intensely scrutinizing management's communication and the long-term value of their combination vaccine pipeline.

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Aventura, FL.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir is currently a major focal point for traders ahead of its upcoming earnings report, with the community deeply divided between bullish investors who anticipate a blowout performance fueled by AI adoption and skeptics who argue that current valuation multiples are unsustainable. Discussion is dominated by heated debates over the company's long-term profitability, intense speculation regarding potential institutional manipulation of price action, and heightened anxiety over the significant implied volatility priced into the stock's options.

SoFi Technologies, Inc. is a financial service platform, which engages in the provision of student loan refinancing options to the private student loan market. It operates through the following segments: Lending, Technology Platform, and Financial Services. The Lending segment offers personal loans, student loans, home loan products, and related servicing activities. The Technology Platform segment focuses on technology products and solutions revenue. The Financial Services segment includes the SoFi Money product, SoFi Invest product, SoFi Credit Card product, SoFi Relay personal finance management product, and other financial services. The company was founded in April 2011 and is headquartered in San Francisco, CA.

SoFi Technologies Inc

SoFi Technologies is experiencing significant volatility as investors debate the company's long-term growth potential and fintech ecosystem against a backdrop of institutional short interest and market-wide macroeconomic uncertainty. While some in the community see the recent price action as a shakeout for long-term accumulation, others remain focused on concerns regarding valuation, EPS growth, and the competitive pressures from legacy financial institutions.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Earnings Preview: Goldman Sachs BDC (GSBD) Q2 Earnings Expected to Decline

Goldman Sachs BDC (GSBD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

FinWise Bancorp (FINW) Lags Q2 Earnings Estimates

FinWise Bancorp (FINW) delivered earnings and revenue surprises of -37.50% and +18.09%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Goldman Sachs BDC, Inc. Schedules Earnings Release and Conference Call to Announce Second Quarter 2026 Results

Goldman Sachs BDC, Inc. (GS BDC) (NYSE: GSBD) announced today that it will report its second quarter ended June 30, 2026 financial results after the market closes on Thursday, August 6, 2026. GS BDC will also host an earnings conference call on Friday, August 7, 2026 at 9:00 am Eastern Time to...

Goldman Sachs BDC And Ares Capital Both Held Their Dividends, But Only One Is Earning It

Goldman Sachs BDC Q1 Earnings Call Highlights

Goldman Sachs BDC Q1 Earnings Call Highlights...

Goldman Sachs BDC (GSBD) Misses Q1 Earnings and Revenue Estimates

Goldman Sachs BDC (GSBD) delivered earnings and revenue surprises of -22.81% and -7.75%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Goldman Sachs BDC, Inc. Reports March31, 2026 Financial Results and Announces Second Quarterly 2026 Base Dividend of $0.32 Per Share.

Goldman Sachs BDC, Inc. (GSBD, the Company, we, us, or our) (NYSE: GSBD) today reported financial results for the first quarter ended March 31, 2026 and filed its Form 10-Q with the U.S. Securities...

Horizon Technology Finance (HRZN) Q1 Earnings Match Estimates

Horizon Technology Finance (HRZN) delivered earnings and revenue surprises of +2.70% and +7.40%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Goldman Sachs BDC (GSBD) Projected to Post Earnings on Thursday

Goldman Sachs BDC (NYSE:GSBD) will be releasing its Q1 2026 earnings after the market closes on Thursday, May 7. (View Earnings Report at...

Goldman Sachs BDC, Inc. (NYSE:GSBD) Receives Average Rating of "Reduce" from Analysts

Shares of Goldman Sachs BDC, Inc. (NYSE:GSBD - Get Free Report) have received an average recommendation of "Reduce" from the six ratings firms that are currently covering the firm, MarketBeat Ratings...

$GSBD Q1 '26 Earnings Results & Recap

• Reported GAAP EPS of -$0.12 down -144.44% YoY
• Reported revenue of $10.35M down -79.56% YoY
• Goldman Sachs BDC, Inc. declared a quarterly base distribution of $0.32 per share payable on or about July 28, 2026, and authorized an additional stock repurchase program up to $75,000 of common stock.

Goldman Sachs BDC, Inc. invests in middle market companies located in the United States. The fund targets companies operating in the software, health technology information technology, commercial services and textiles industries. The company was founded in September 2012 and is headquartered in New York, NY.

Goldman Sachs BDC Inc

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Earnings

Fundamentals

Info

GSBDGoldman Sachs BDC Inc

Fundamentals

Connect Stocktwits to ChatGPT

Latest GSBD News